ATOS
Price
$0.92
Change
+$0.10 (+12.20%)
Updated
Jul 29, 11:29 AM (EDT)
Capitalization
105.54M
20 days until earnings call
BEAM
Price
$20.83
Change
-$0.89 (-4.10%)
Updated
Jul 28 closing price
Capitalization
2.09B
14 days until earnings call
Interact to see
Advertisement

ATOS vs BEAM

Header iconATOS vs BEAM Comparison
Open Charts ATOS vs BEAMBanner chart's image
Atossa Therapeutics
Price$0.92
Change+$0.10 (+12.20%)
Volume$2K
Capitalization105.54M
Beam Therapeutics
Price$20.83
Change-$0.89 (-4.10%)
Volume$1.77M
Capitalization2.09B
ATOS vs BEAM Comparison Chart in %
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. BEAM commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a Buy and BEAM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (ATOS: $0.82 vs. BEAM: $20.83)
Brand notoriety: ATOS and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 76% vs. BEAM: 80%
Market capitalization -- ATOS: $105.54M vs. BEAM: $2.09B
ATOS [@Biotechnology] is valued at $105.54M. BEAM’s [@Biotechnology] market capitalization is $2.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ATOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ATOS’s TA Score: 3 bullish, 6 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ATOS.

Price Growth

ATOS (@Biotechnology) experienced а -3.72% price change this week, while BEAM (@Biotechnology) price change was -0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.63%. For the same industry, the average monthly price growth was +18.57%, and the average quarterly price growth was +45.76%.

Reported Earning Dates

ATOS is expected to report earnings on Nov 17, 2025.

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+5.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.1B) has a higher market cap than ATOS($106M). ATOS YTD gains are higher at: -13.452 vs. BEAM (-16.008). ATOS has higher annual earnings (EBITDA): -28.04M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ATOS (65.1M). ATOS has less debt than BEAM: ATOS (0) vs BEAM (158M). BEAM has higher revenues than ATOS: BEAM (63.6M) vs ATOS (0).
ATOSBEAMATOS / BEAM
Capitalization106M2.1B5%
EBITDA-28.04M-399.03M7%
Gain YTD-13.452-16.00884%
P/E RatioN/AN/A-
Revenue063.6M-
Total Cash65.1M1.22B5%
Total Debt0158M-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATOSBEAM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLYCX37.32N/A
N/A
Nuveen Large Cap Select C
EPGAX21.68N/A
N/A
Fidelity Advisor Equity Growth A
SVTAX11.19N/A
N/A
SEI Global Managed Volatility F (SIMT)
MWEMX49.88N/A
N/A
MFS Global Equity R6
NRILX15.78N/A
N/A
Neuberger Berman International Sel R6